Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients
Clinical trial NCT05825443 · RECRUITING
Trial details
- NCT number
- NCT05825443
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-10
- Primary completion
- 2026-04-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.